Skip to main content

Xavier Montalban Gairín

I am Chair of the Department of Neurology since 2012 and director of the Multiple Sclerosis Center of Catalonia (Cemcat) since 2007 at the Vall d'Hebron University Hospital. I am the head of the Neuroimmunology Research Group at Vall d’Hebron Research Institute (VHIR) since 1995. I am Professor of Neurology at the Autonomous University of Barcelona (UAB) since 2006 and at the University of Vic - Central University of Catalonia (UVic-UCC) since 2021.

Institutions of which they are part

Head of group
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Neurology
General Hospital
Director
Multiple Sclerosis Centre of Catalonia

Xavier Montalban Gairín

Institutions of which they are part

Head of group
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Neurology
General Hospital
Director
Multiple Sclerosis Centre of Catalonia

I am Chair of the Department of Neurology since 2012 and director of the Multiple Sclerosis Center of Catalonia (Cemcat) since 2007 at the Vall d'Hebron University Hospital. I am the head of the Neuroimmunology Research Group at Vall d’Hebron Research Institute (VHIR) since 1995. I am Professor of Neurology at the Autonomous University of Barcelona (UAB) since 2006 and at the University of Vic - Central University of Catalonia (UVic-UCC) since 2021.

I obtained my MD (1983) and PhD (1990) from UAB, and I completed my postgraduate fellowship at St. Thomas' Hospital and the National Hospital for Neurology and Neurosurgery in London. I obtained a Diploma in Comprehensive of Healthcare Institutions Management from ESADE (2005).

In addition to the positions I currently hold, between 2017 and 2020 I served as Professor of Medicine and Director of the Division of Neurology at the University of Toronto and as Director of the MS Center at St Michael's Hospital in the same city.

Since January 2023 I am the chair of the International Advisory Committee on Clinical Trials in Multiple Sclerosis sponsored by ECTRIMS and the National Multiple Sclerosis Society (NMSS), one of the most influential Committee in MS worldwide.

Regarding other leadership roles I am past President (2014-2016) and current Honorary Member of the Council of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). I’m also Board Member of the European Charcot Foundation, as well as serving on numerous local, national and international boards and committees.

My scientific production acrues over 800 scientific papers published in peer-reviewed journals, amounting? more than 52,000 citations and a Scopus H-Index of 101. Over the last consecutive five years I have ranked among the Clarivate most cited researchers.

I have been the Principal Investigator (PI) or Collaborator in more than 35 competitive Projects and have participated as PI in more than 150 clinical trials.

Of Note, I am the recipient of the 2022 John Dystel Prize for MS Research, awarded jointly by the National Multiple Sclerosis Society (NMSS) and the American Academy of Neurology (AAN). I’m the winner of the 2023 Charcot Award granted by the Multiple Sclerosis International Federation (MSIF), which recognises a lifetime of achievement in outstanding research into understanding and treating MS.

Projects

Convocatoria Juan Rodés (Preliminar: Enfermedades neurológicas mediadas por anticuerpos antineuronales)

IP: Tintore Subirana, Mar
Collaborators: Arqueros Sánchez, Genoveva, Montalban Gairín, Xavier, Izquierdo Sans , Miriam
Funding agency: Instituto de Salud Carlos III
Funding: 180000
Reference: JR22/00071
Duration: 20/02/2023 - 19/02/2026

Incorporación al CIBER de enfermedades neurodegenerativas como grupo de esclerosis múltiple

IP: Comabella Lopez, Manuel
Collaborators: Rio Izquierdo, Jordi, Tur Gomez, Carmen, Montalban Gairín, Xavier, Midaglia Fernandez, Luciana, Castillo Justribo, Joaquin, Pinteac , Rucsanda, Fissolo , Nicolás Miguel
Funding agency: Instituto de Salud Carlos III
Funding: 48000
Reference: CB22/05/00047
Duration: 13/12/2022 - 12/12/2023

ResEM Project - Desarrollo de un modelo global de reserva funcional y estructural del sistema nervioso central en esclerosis múltiple

IP: Sastre Garriga, Jaume
Collaborators: Auger Acosta, Cristina, Santoyo Medina, Carme, Arevalo Navines, M Jesus, Montalban Gairín, Xavier, Gutiérrez Ruiz, Lucía, Mongay Ochoa, Neus
Funding agency: Instituto de Salud Carlos III
Funding: 157300
Reference: PI22/00750
Duration: 01/01/2023 - 31/12/2025

SGR-Cat 2021: Neuroimmunologia Clínica

IP: Montalban Gairín, Xavier
Collaborators: Guerrero Perez, Ana Isabel, Nos Llopis, Carlos, Malhotra Sareen, Sunny, Graells Salvador, José Ant., SGR-Cat 2021: Neuroimmunologia Clínica, Sastre Garriga, Jaume, Rio Izquierdo, Jordi, Galán Cartaña, Ingrid, Rosalia Horno Ocaña, Comabella Lopez, Manuel, Serrano Mascarós, Andrea, Capell Maymo, Margarida, Sánchez Pous, Samuel, Anglada Clofent, Elisenda, Cabello , Sergio, Tur Gomez, Carmen, SGR-Cat 2021: Neuroimmunologia Clínica, Eixarch Ahufinger, Herena, Santoyo Medina, Carme, Tintore Subirana, Mar, Arevalo Navines, M Jesus, Meza Murillo, Edwin Roger, Augusto Cesar Sao Aviles, Robles Sanchez, Miguel Angel, Muñoz Valdivielso, Dunia, Espejo Ruiz, Carmen, Filló Papiol, Nuria, Rodríguez Barranco, Marta, Loyola Sanmillan, Gaizka, Resina Salles, Mireia, Vidal Jordana, Angela, Gutiérrez Ruiz, Lucía, Zabalza de Torres, Ana, Vergara Ruiz, Sergio, Javier Villacieros Álvarez, Garcia Merida, Rafael, SGR-Cat 2021: Neuroimmunologia Clínica, Midaglia Fernandez, Luciana, Cobo Calvo, Alvaro, Mongay Ochoa, Neus, Castillo Justribo, Joaquin, Fraga Pereira, Milagros, Rodriguez Acevedo, Breogan, Miguez Gonzalez, Andres, SGR-Cat 2021: Neuroimmunologia Clínica, Castillo Juarez, Mireia, Pinteac , Rucsanda, Fissolo , Nicolás Miguel
Funding agency: AGAUR no fer servir-correcte 4301-37
Funding: 40000
Reference: 2021 SGR 00782
Duration: 01/01/2022 - 31/12/2024

Related news

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

Dr. Carmen Espejo and Dr. Georgina Arrambide, researchers at Cemcat and Vall d'Hebron Research Institute, are the first authors of the article.

The research findings propose to modify the McDonald 2017 criteria, only in those in whom diagnosis using the current criteria is not possible.

Related professionals

Montse  Adell  Trape

Montse Adell Trape

General Surgery
Read more
Ana Díez Izquierdo

Ana Díez Izquierdo

Main researcher
Growth and Development
Read more
Eva Carolina Watson  Badia

Eva Carolina Watson Badia

Predoctoral researcher
Multidisciplinary Nursing Research Group
Read more
Laura Donadeu Casassas

Laura Donadeu Casassas

Main researcher
Nephrology and kidney transplantation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.